The Impact of the ASPREE Trial on Aspirin Use in Older Adults
Aspirin, a widely used medication worldwide, has long been prescribed as a preventive measure against cardiovascular disease, particularly among older adults. For decades, the benefits of aspirin, especially its antiplatelet properties, have guided its use in primary prevention. However, the advent of the ASPREE (ASPirin in Reducing Events in the Elderly) trial has ignited fresh […]
The Impact of the ASPREE Trial on Aspirin Use in Older Adults Read More »